OpinionAugust 25, 2021
Alzheimer’s, Inc.: When a Hypothesis Becomes Too Big to Fail
This summer’s controversy surrounding the FDA’s shocking approval of the drug aducanumab provides a window into a scientific field in crisis
Stories by Daniel R. George
Daniel R. George, Ph.D., M.Sc., is co-author of American Dementia: Brain Health in an Unhealthy Society (Johns Hopkins University Press). www.americandementia.com.